Boston Scientific Sees Q4 Adj EPS $0.77-$0.79 vs $0.84 Est; Sees Sales $5.127B-$5.233B vs $5.404B Est
Benzinga Newsdesk 3 weeks ago
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Boston Scientific (NYSE:BSX) is looking for Q4 Adj EPS of $0.77-$0.79 vs $0.84 analyst estimate. sees sales of $5.127 billion-$5.233 billion vs $5.404 billion analyst estimate.
Boston Scientific (NYSE:BSX) is looking for Q4 Adj EPS of $0.77-$0.79 vs $0.84 analyst estimate. sees sales of $5.127 billion-$5.233 billion vs $5.404 billion analyst estimate.
More on BSX
Benzinga
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 YearsBoston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 2.14% on an annualized basis producing an average annual return of 15.02%. Currently, Boston Scientific has a market…

